SCHEMBL32680418

SCHEMBL32680418

Cc1ccc2c(c1)OC1(O)c3ccccc3C(=O)C21O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.54
TDP2 O95551 5/20 0.54
APAF1 O14727 3/20 0.54
KDM4E B2RXH2 3/20 0.54
NSD2 O96028 2/20 0.54
KMT2A Q03164 2/20 0.54
RECQL P46063 1/20 0.54
SAE1 Q9UBE0 1/20 0.54
UBA2 Q9UBT2 1/20 0.54
L3MBTL1 Q9Y468 2/20 0.49
ABL1 P00519 1/20 0.49
GALK1 P51570 1/20 0.49
BLM P54132 1/20 0.49
PPP1CA P62136 1/20 0.49
RIN1 Q13671 1/20 0.49
SENP8 Q96LD8 1/20 0.49
SENP7 Q9BQF6 1/20 0.49
SENP6 Q9GZR1 1/20 0.49
ALDH1A1 P00352 8/20 0.46
SMAD3 P84022 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15642448 1.00 MAPT (0.54) MAPTTDP2APAF1KDM4ENSD2
SCHEMBL15642240 0.89 TDP2 (0.54) MAPTTDP2APAF1KDM4ENSD2
SCHEMBL15642056 0.84 MAPT (0.56) MAPTTDP2APAF1KDM4ENSD2
SCHEMBL15686104 0.84 MAPT (0.56) MAPTTDP2APAF1KDM4ENSD2
SCHEMBL15642590 0.83 MAPT (0.48) MAPTTDP2APAF1KDM4ENSD2
SCHEMBL15642457 0.83 MAPT (0.48) MAPTTDP2APAF1KDM4ENSD2
SCHEMBL32593909 0.83 MAPT (0.48) MAPTTDP2APAF1KDM4ENSD2
SCHEMBL32680435 0.83 MAPT (0.48) MAPTTDP2APAF1KDM4ENSD2
SCHEMBL15642170 0.83 MAPT (0.48) MAPTTDP2APAF1KDM4ENSD2
SCHEMBL15642030 0.83 MAPT (0.52) MAPTTDP2APAF1KDM4ENSD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3597184-B1 INDANONE DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALTS OR OPTICAL ISOMERS THEREOF, PREPARATION METHOD FOR SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING VIRAL DISEASES KOREA RES INST CHEMICAL TECH (KR) 2026-03-04 EP disclosed